Essential hypertension. Part I: Definition and etiology

Circulation

Volumn 101, Issue 3, 2000, Pages 329-335

  Carretero, Oscar A ^a   Oparil, Suzanne ^b  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Hypertension; Pathology

Indexed keywords

GLUCOCORTICOID; INSULIN;

AUTOSOMAL DOMINANT INHERITANCE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ESSENTIAL HYPERTENSION; GENETIC ASSOCIATION; HUMAN; HYPERALDOSTERONISM; INSULIN RESISTANCE; LIDDLE SYNDROME; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0034711753     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.3.329     Document Type: Review

References (34)

1. Parati G, Di Rienzo M, Ulian L, Santucciu C, Girard A, Elghozi J-L, Mancia G. Clinical relevance of blood pressure variability. J Hypertens. 1998;16(suppl 3):S25-S33.
2. Cutler JA. High blood pressure and end-organ damage. J Hypertens. 1996;14(suppl 6):S3-S6.
3. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997;157:2413-2446.
4. Luft FC. Molecular genetics of human hypertension. J Hypertens. 1998; 16:1871-1878.
5. INTERSALT Co-operative Research Group. Sodium, potassium, body mass, alcohol and blood pressure: the INTERSALT study. J Hypertens. 1988;6(suppl. 4):S584-S586.
6. Sever PS, Poulter NR. A hypothesis for the pathogenesis of essential hypertension: the initiating factors. J Hypertens. 1989;7(suppl 1):S9-S12.
7. Phillips MI. Is gene therapy for hypertension possible? Hypertension. 1999;33:8-13. Editorial.
8. Beilin LJ. The fifth Sir George Pickering memorial lecture: epitaph to essential hypertension: a preventable disorder of known aetiology? J Hypertens. 1988;6:85-94.
9. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N. A clinical trial of the effects of dietary patterns on blood pressure: DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-1124.
10. Krotkiewski M, Mandroukas K, Sjöström L, Sullivan L, Wetterqvist H, Björntorp P. Effects of long-term physical training on body fat, metabolism, and blood pressure in obesity. Metabolism. 1979;28:650-658.
11. Petrella RJ. How effective is exercise training for the treatment of hypertension? Clin J Sport Med. 1998;8:224-231.
12. Williams RR, Hunt SC, Hopkins PN, Hasstedt SJ, Wu LL, Lalouel JM. Tabulations and expectations regarding the genetics of human hypertension. Kidney Int. 1994;45(suppl 44):S-57-S-64.
13. Lifton RP. Molecular genetics of human blood pressure variation. Science. 1996;272:676-680.
14. Lifton RP. Genetic determinants of human hypertension. Proc Natl Acad Sci U S A. 1995;92:8545-8551.
15. Dluhy RG, Lifton RP. Glucocorticoid-remediable aldosteronism (GRA): diagnosis, variability of phenotype and regulation of potassium homeostasis. Steroids. 1995;60:48-51.
16. Gates LJ, MacConnachie AA, Lifton RP, Haites NE, Benjamin N. Variation of phenotype in patients with glucocorticoid remediable aldosteronism. J Med Genet. 1996;33:25-28.
17. Findling JW, Raff H, Hansson JH, Lifton RP. Liddle's syndrome: prospective genetic screening and suppressed aldosterone secretion in an extended kindred. J Clin Endocrinol Metab. 1997;82:1071-1074.
18. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP. Hypertension caused by a truncated sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet. 1995;11:76-82.
19. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet. 1995;10:394-399.
20. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
21. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo AP, Hata A, Corvol P, Lalouel JM. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 1997;60:1448-1460.
22. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99:1786-1797.
23. Corvol P, Jeunemaitre X. Molecular genetics of human hypertension: role of angiotensinogen. Endocr Rev. 1997;18:662-677.
24. Ashley FW Jr, Kannel WB. Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis. 1974;27: 103-114.
25. Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension. 1992;20:38-45.
26. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 1989;321:580-585.
27. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 1978; 298:1-6.
28. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
29. Anderson EA, Mark AL. The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 1993;21: 136-141. Editorial.
30. Díez J. Insulin-like growth factor I in essential hypertension. Kidney Int. 1999;55:744-759.
31. Mark AL, Correia M, Morgan DA, Shaffer RA, Haynes WG. Obesity-induced hypertension: new concepts from the emerging biology of obesity [state-of-the-art lecture]. Hypertension. 1999;33:537-541.
32. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88:2460-2470.
33. Prisant LM, Alpert BS, Robbins CB, Berson AS, Hayes M, Cohen ML, Sheps SG. American National Standard for nonautomated sphygmomanometers: summary report. Am J Hypertens. 1995;8:210-213.
34. Black HR, Weltin G, Jaffe CC. The limited echocardiogram: a modification of standard echocardiography for use in the routine evaluation of patients with systemic hypertension. Am J Cardiol. 1991;67:1027-1030. Editorial.